Victory For Takeda Abbott In Prostate Drug Patent Suit
A jury has upheld a patent for a prostate cancer treatment held by Takeda Abbott Pharmaceuticals, marking a victory for the company in its litigation against pharmaceutical companies QLT Inc. and...To view the full article, register now.
Already a subscriber? Click here to view full article